Le Lézard
Classified in: Health
Subjects: CCA, FVT

Accuray To Report Fiscal 2019 Fourth Quarter and Full Year Financial Results on August 15, 2019


SUNNYVALE, Calif., July 19, 2019 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report results for its fourth quarter and fiscal year 2019 ended June 30, 2019 on Thursday, August 15, 2019 after the market close. Management will host a conference call to review the results at 1:30 p.m. PT/4:30 p.m. ET on the same day.

Accuray Incorporated (PRNewsFoto/Accuray Incorporated) (PRNewsFoto/Accuray Incorporated)

The conference call dial-in numbers are 855-867-4103 (USA) or 262-912-4764 (International).  In addition, a dial up replay of the conference call will be available approximately one hour after the call's conclusion for one week.  The replay number is 855-859-2056 (USA), or 404-537-3406 (International), Conference ID: 3297842.

A live webcast of the call will also be available from the Investor Relations section of the Company's website at investors.accuray.com.  A webcast replay can be accessed on the website and will remain available until Accuray announces its results for the first quarter of fiscal 2020.

About Accuray
Accuray Incorporated (Nasdaq: ARAY) develops, manufactures and sells radiotherapy systems that are intended to make cancer treatments shorter, safer, personalized and more effective, ultimately enabling patients to live longer, better lives. Our radiation treatment delivery systems in combination with fully-integrated software solutions set the industry standard for precision and cover the full range of radiation therapy and radiosurgery procedures. For more information, please visit www.accuray.com or follow us on Facebook, LinkedIn, Twitter and YouTube.

Contacts:

Investor Contacts: 
Michael Polyviou
EVC Group LLC 
732-933-2754
mpolyviou@evcgroup.com

Media Contacts
Beth Kaplan
Accuray Inc
+1 (408) 789-4426
bkaplan@accuray.com

 

SOURCE Accuray Incorporated


These press releases may also interest you

at 19:45
Suncoast Neuroscience Associates is recruiting for a clinical research study to evaluate an investigational medication in people diagnosed with Parkinson's disease who are experiencing symptoms such as seeing things/hearing things that may not...

at 18:21
This summer, Aflac, the leader in supplemental insurance sales at U.S. worksites, is bringing My Special Aflac Ducks to Roswell Park Comprehensive Cancer Center. My Special Aflac Duck, designed by Sproutel, is a social robot that uses medical play,...

at 18:00
Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") , a specialty hospital management group and an operator of the network of radiotherapy and diagnostic imaging centers in China, today announced its unaudited consolidated...

at 17:38
Altaire Pharmaceuticals, Inc., announces today that it is correcting its 08.22.19 Announcement of a Voluntary Recall for Veterinary Ophthalmic drug products and lots, within expiry, identified below.  Corrections are being made only for the...

at 17:05
Golden Leaf Holdings Ltd. ("Golden Leaf" or the "Company") , a pioneer cannabis oil solutions company and dispensary operator built around recognized brands, has announced the completion of the debenture payments. On July 2, 2019, the Company...

at 17:00
"Patients and Providers need an easy, affordable way to understand their genetic data, monitor their health outcomes and obtain vetted personalized products. Our partnership with Breakthrough Genomics will assure all users have access to actionable...



News published on 19 july 2019 at 07:30 and distributed by: